The link-up will enable the company to identify new motor neurone disease biomarkers
The link-up will enable the company to identify new motor neurone disease biomarkers
MDG1011 is a therapy which aims to improve outcomes for in patients with high-risk blood cancers
Treatment involves the treatment of adults with metastatic castration-resistant prostate cancer
Companies will collaborate to boost novel treatments for individuals with geographic atrophy
Study has been focusing on atogepant for the prevention of episodic migraine attacks
IMM-1-104 found to be well tolerated with no dose limiting toxicities or serious adverse events
Brachytherapy is a precise type of radiotherapy that can be used to treat several cancers
Effective treatment of AID is still a considerable area of unmet medical requirements
Link-up has already delivered data showing the promise of nanoparticle-formulated doggybone DNA
Collaboration will further boost its promising pipeline of cancer treating therapies
Drug discovery platform is a tool specifically designed for gene-to-function studies using human macrophages
Group B streptococcus vaccine study will involve adult groups with and without underlying conditions
Efti’s targeting activation of antigen-presenting cells delivers an adaptive immunity to fight cancer
The Oxford-based biotech company has secured £13.2m to progress world’s vital treatment development
Product delivers epigenetic information from a single low-input DNA library without medical treatment